AstraZeneca PLC (AZNCF)
OTCMKTS · Delayed Price · Currency is USD
188.50
+0.78 (0.42%)
Nov 26, 2025, 4:00 PM EST
AstraZeneca Market Cap
AstraZeneca has a market cap or net worth of $287.99 billion as of November 26, 2025. Its market cap has increased by 48.18% in one year.
Market Cap
287.99B
Enterprise Value
312.21B
Revenue
58.13B
Ranking
n/a
PE Ratio
30.64
Stock Price
$188.50
Market Cap Chart
Since May 28, 1993, AstraZeneca's market cap has increased from 7.10B to 287.99B, an increase of 3,955.69%. That is a compound annual growth rate of 12.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 27, 2025 | 287.99B | 41.75% |
| Dec 31, 2024 | 203.17B | -2.91% |
| Dec 29, 2023 | 209.27B | -0.08% |
| Dec 30, 2022 | 209.44B | 15.06% |
| Dec 31, 2021 | 182.03B | 38.68% |
| Dec 31, 2020 | 131.26B | -0.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Elite Pharmaceuticals | 566.42M |
| Glass House Brands | 508.04M |
| CytoDyn | 416.43M |
| Northwest Biotherapeutics | 389.02M |
| American Oncology Network | 346.66M |
| Silence Therapeutics | 323.08M |
| Nika Pharmaceuticals | 259.96M |